DE LUCA, G., M. VERDOIA, M. CERCEK, L. O. JENSEN, M. VAVLUKIS, L. CALMAC, T. JOHNSON, G. R. FERRER, V. GANYUKOV, W. WOJAKOWSKI, T. KINNAIRD, C. VAN BIRGELEN, Y. COTTIN, A. IJSSELMUIDEN, B. TUCCILLO, F. VERSACI, K. J . ROYAARDS, J. TEN BERG, M. LAINE, M. DIRKSEN, M. SIVIGLIA, G. CASELLA, Petr KALA, J. L. D. GIL, A. BANNING, V. BECERRA, C. DE SIMONE, A. SANTUCCI, X. CARRILLO, A. SCOCCIA, G. AMOROSO, A. LUX, T. KOVARNIK, P. DAVLOUROS, J. MEHILLI, G. GABRIELLI, X. F. RIOS, N. BAKRACESKI, S. LEVESQUE, G. CIRRINCIONE, V. GUIDUCCI, M. KIDAWA, L. SPEDICATO, L. MARINUCCI, P. LUDMAN, F. ZILIO, G. GALASSO, E. FABRIS, M. MENICHELLI, A. GARCIA-TOUCHARD, S. MANZO, G. CAIAZZO, J. MOREU, J. S. FORES, L. DONAZZAN, L. VIGNALI, R. TELES, E. BENIT, P. AGOSTONI, F. B. OJEDA, H. LEHTOLA, S. CAMACHO-FREIERE, A. KRAAIJEVELD, Y. ANTTI, M. BOCCALATTE, P. DEHARO, I. L. MARTINEZ-LUENGAS, B. SCHELLER, D. ALEXOPOULOS, R. MORENO, E. KEDHI, G. UCCELLO, B. FAURIE, A. G. BARRIOS, F. S. DI UCCIO, B. WILBERT, P. SMITS, G. CORTESE, G. PARODI and D. DUDEK. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI. Journal of the American College of Cardiology. New York: Elsevier Science INC, 2020, vol. 76, No 20, p. 2321-2330. ISSN 0735-1097. Available from: https://dx.doi.org/10.1016/j.jacc.2020.09.546.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI
Authors DE LUCA, G. (guarantor), M. VERDOIA, M. CERCEK, L. O. JENSEN, M. VAVLUKIS, L. CALMAC, T. JOHNSON, G. R. FERRER, V. GANYUKOV, W. WOJAKOWSKI, T. KINNAIRD, C. VAN BIRGELEN, Y. COTTIN, A. IJSSELMUIDEN, B. TUCCILLO, F. VERSACI, K. J . ROYAARDS, J. TEN BERG, M. LAINE, M. DIRKSEN, M. SIVIGLIA, G. CASELLA, Petr KALA (203 Czech Republic, belonging to the institution), J. L. D. GIL, A. BANNING, V. BECERRA, C. DE SIMONE, A. SANTUCCI, X. CARRILLO, A. SCOCCIA, G. AMOROSO, A. LUX, T. KOVARNIK, P. DAVLOUROS, J. MEHILLI, G. GABRIELLI, X. F. RIOS, N. BAKRACESKI, S. LEVESQUE, G. CIRRINCIONE, V. GUIDUCCI, M. KIDAWA, L. SPEDICATO, L. MARINUCCI, P. LUDMAN, F. ZILIO, G. GALASSO, E. FABRIS, M. MENICHELLI, A. GARCIA-TOUCHARD, S. MANZO, G. CAIAZZO, J. MOREU, J. S. FORES, L. DONAZZAN, L. VIGNALI, R. TELES, E. BENIT, P. AGOSTONI, F. B. OJEDA, H. LEHTOLA, S. CAMACHO-FREIERE, A. KRAAIJEVELD, Y. ANTTI, M. BOCCALATTE, P. DEHARO, I. L. MARTINEZ-LUENGAS, B. SCHELLER, D. ALEXOPOULOS, R. MORENO, E. KEDHI, G. UCCELLO, B. FAURIE, A. G. BARRIOS, F. S. DI UCCIO, B. WILBERT, P. SMITS, G. CORTESE, G. PARODI and D. DUDEK.
Edition Journal of the American College of Cardiology, New York, Elsevier Science INC, 2020, 0735-1097.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 24.094
RIV identification code RIV/00216224:14110/20:00117705
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jacc.2020.09.546
UT WoS 000600579800005
Keywords in English COVID-19; primary angioplasty; STEMI
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/1/2021 12:41.
Abstract
BACKGROUND The fear of contagion during the coronavirus disease-2019 (COVID-19) pandemic may have potentially refrained patients with ST-segment elevation myocardial infarction (STEMI) from accessing the emergency system, with subsequent impact on mortality. OBJECTIVES The ISACS-STEMI COVID-19 registry aims to estimate the true impact of the COVID-19 pandemic on the treatment and outcome of patients with STEMI treated by primary percutaneous coronary intervention (PPCI), with identification of "at-risk" patient cohorts for failure to present or delays to treatment. METHODS This retrospective registry was performed in European high-volume PPCI centers and assessed patients with STEMI treated with PPPCI in March/April 2019 and 2020. Main outcomes are the incidences of PPCI, delayed treatment, and in-hospital mortality. RESULTS A total of 6,609 patients underwent PPCI in 77 centers, located in 18 countries. In 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio: 0.811; 95% confidence interval: 0.78 to 0.84; p < 0.0001). The heterogeneity among centers was not related to the incidence of death due to COVID-19. A significant interaction was observed for patients with arterial hypertension, who were less frequently admitted in 2020 than in 2019. Furthermore, the pandemic was associated with a significant increase in door-to-balloon and total ischemia times, which may have contributed to the higher mortality during the pandemic. CONCLUSIONS The COVID-19 pandemic had significant impact on the treatment of patients with STEMI, with a 19% reduction in PPCI procedures, especially among patients suffering from hypertension, and a longer delay to treatment, which may have contributed to the increased mortality during the pandemic. (C) 2020 by the American College of Cardiology Foundation.
PrintDisplayed: 3/10/2024 16:37